Your browser doesn't support javascript.
loading
A randomized clinical trial of transdermal (gel) versus oral estrogen for endometrial preparation in frozen embryo transfer cycle
Carvalho, Mariana Oliva Cassará; Lima, Sônia Maria Rolim Rosa; Glina, Claudia Godman; Tso, Leopoldo de Oliveira; Romano, Rodrigo Sabato; Glina, Sidney; Busso, Newton Eduardo; Busso, Cristiano Eduardo.
Afiliação
  • Carvalho, Mariana Oliva Cassará; Santa Casa de Sao Paulo School of Medical Sciences. Department of Obstetrics and Gynecology. São Paulo. BR
  • Lima, Sônia Maria Rolim Rosa; Santa Casa de Sao Paulo School of Medical Sciences. Department of Obstetrics and Gynecology. São Paulo. BR
  • Glina, Claudia Godman; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
  • Tso, Leopoldo de Oliveira; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
  • Romano, Rodrigo Sabato; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
  • Glina, Sidney; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
  • Busso, Newton Eduardo; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
  • Busso, Cristiano Eduardo; Project Alliance of Assisted Fertility Laboratories/BETA. São Paulo. BR
Rev. Assoc. Med. Bras. (1992, Impr.) ; 70(5): e20231548, 2024. tab, graf
Article em En | LILACS-Express | LILACS | ID: biblio-1558920
Biblioteca responsável: BR1.1
ABSTRACT
SUMMARY

OBJECTIVE:

The aim of this study was to compare endometrial thickness with the use of transdermal estrogen (gel) versus oral estrogen (pills) for endometrial preparation in the frozen embryo transfer cycle and serum estrogen concentrations during the preparation cycle, side effects, and chemical and clinical pregnancy rates.

METHODS:

This was a prospective, randomized controlled trial of women undergoing endometrial preparation for cryopreserved blastocyst transfer. A total of 88 women were randomized, of which 82 completed the study protocol. Of this group, 44 received 6 mg/day of estradiol valerate orally (pills group) and 38 received 4.5 mg/day of estradiol hemihydrate transdermally (gel group). Endometrial thickness was measured using transvaginal ultrasound between the 7 and 10th day of the cycle. Serum estradiol concentrations were measured on the day of initiating the cycle, on control transvaginal ultrasounds, and on the day of embryo transfer. Side effects were documented at each study visit. p<0.05 were adopted as statistically significant. The groups were compared using Student's t-test for continuous variables and chi-square or Fisher's exact test for categorical variables.

RESULTS:

There were no significant group differences (p>0.05) in endometrial thickness, biochemical and clinical pregnancy rates, miscarriage rate, blood estradiol concentrations, duration of estradiol administration, or cycle cancellation rates.

CONCLUSION:

Endometrial preparation with transdermal estrogen yielded similar reproductive outcomes to oral estrogen with fewer side effects.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Idioma: En Revista: Rev. Assoc. Med. Bras. (1992, Impr.) Assunto da revista: Educa‡Æo em Sa£de / GestÆo do Conhecimento para a Pesquisa em Sa£de / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: LILACS Idioma: En Revista: Rev. Assoc. Med. Bras. (1992, Impr.) Assunto da revista: Educa‡Æo em Sa£de / GestÆo do Conhecimento para a Pesquisa em Sa£de / MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil